147 related articles for article (PubMed ID: 35732909)
1. Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer.
Roy S; Saha S; Dhar D; Chakraborty P; Singha Roy K; Mukherjee C; Gupta A; Bhattacharyya S; Roy A; Sengupta S; Roychoudhury S; Nath S
Cancer Gene Ther; 2022 Nov; 29(11):1697-1706. PubMed ID: 35732909
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.
Pan X; Zhou T; Tai YH; Wang C; Zhao J; Cao Y; Chen Y; Zhang PJ; Yu M; Zhen C; Mu R; Bai ZF; Li HY; Li AL; Liang B; Jian Z; Zhang WN; Man JH; Gao YF; Gong WL; Wei LX; Zhang XM
Nat Med; 2011 Jun; 17(6):708-14. PubMed ID: 21572428
[TBL] [Abstract][Full Text] [Related]
3. CUEDC2: an emerging key player in inflammation and tumorigenesis.
Man J; Zhang X
Protein Cell; 2011 Sep; 2(9):699-703. PubMed ID: 21976060
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
5. Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability.
Gao YF; Li T; Chang Y; Wang YB; Zhang WN; Li WH; He K; Mu R; Zhen C; Man JH; Pan X; Li T; Chen L; Yu M; Liang B; Chen Y; Xia Q; Zhou T; Gong WL; Li AL; Li HY; Zhang XM
Nat Cell Biol; 2011 Jul; 13(8):924-33. PubMed ID: 21743465
[TBL] [Abstract][Full Text] [Related]
6. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
Trauernicht AM; Kim SJ; Kim NH; Boyer TG
Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
[TBL] [Abstract][Full Text] [Related]
7. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
8. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
9. CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.
Han S; Hao H; Han H; Xue D; Jiao Y; Xie Y; Xu Y; Huangfu L; Fu J; Wang S; Sun H; Li P; Zhou Q
Cells; 2022 Sep; 11(19):. PubMed ID: 36231027
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
[TBL] [Abstract][Full Text] [Related]
11. ERα-36 regulates progesterone receptor activity in breast cancer.
Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
[TBL] [Abstract][Full Text] [Related]
12. RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.
Saikia S; Pal U; Kalita DJ; Rai AK; Sarma A; Kataki AC; Limaye AM
Mol Biol Rep; 2021 Jul; 48(7):5399-5409. PubMed ID: 34264479
[TBL] [Abstract][Full Text] [Related]
13. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
15. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
16. Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics.
Groenendijk FH; Zwart W; Floore A; Akbari S; Bernards R
Breast Cancer Res Treat; 2013 Aug; 140(3):475-84. PubMed ID: 23912957
[TBL] [Abstract][Full Text] [Related]
17. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
19. Expression of
Esmaeili R; Mohammadi S; Jafarbeik-Iravani N; Yadegari F; Olfatbakhsh A; Mazaheri M; Kaviani A; Rezaee M; Majidzadeh-A K
Arch Iran Med; 2021 Mar; 24(3):209-217. PubMed ID: 33878879
[TBL] [Abstract][Full Text] [Related]
20. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.
Zhang PJ; Zhao J; Li HY; Man JH; He K; Zhou T; Pan X; Li AL; Gong WL; Jin BF; Xia Q; Yu M; Shen BF; Zhang XM
EMBO J; 2007 Apr; 26(7):1831-42. PubMed ID: 17347654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
